If you've been following the longevity and biohacking space, you've likely started seeing MOTS-C come up more frequently. Here's what the research actually says — and why it's generating serious interest.
What is MOTS-C?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded within mitochondrial DNA — not nuclear DNA, which makes it unique among known peptides. It was first identified in 2015 by researchers at USC and has since become one of the more studied mitochondria-derived peptides (MDPs).
What does the research show?
Early studies have explored MOTS-C's role in:
- Metabolic regulation — improving insulin sensitivity and glucose uptake in skeletal muscle
- Exercise performance — mimicking some effects of physical activity at the cellular level
- Aging and longevity — levels of MOTS-C naturally decline with age; research is investigating whether supplementation can offset this
- Stress response — MOTS-C appears to help cells adapt to metabolic stress
Why is it getting attention now?
The longevity research community has accelerated significantly over the past decade. MOTS-C sits at the intersection of mitochondrial biology, metabolic health, and aging — three of the most active areas of scientific inquiry. Researchers like David Sinclair and others studying NAD+ pathways have helped bring mitochondrial health into mainstream wellness conversations, creating a broader audience for peptides like MOTS-C.
Who is exploring MOTS-C?
Biohackers, longevity-focused individuals, and researchers interested in metabolic optimization have been the early adopters. As with most peptides, the research is ongoing and evolving.
A note on sourcing
Peptide quality varies significantly by supplier. At Avivim Wellness, our products are sourced with purity and transparency as a priority.
As with any peptide or supplement, consult with a qualified healthcare provider before use.